3 active not recruiting, 1 recruiting, 1 unknown. 5 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 5 | Active not recruiting 3, Recruiting 1, Unknown 1 |
Follow Physiological Effects of Drugs: new trials by email Literature Review of Physiological Effects of Drugs trials Research Report on Physiological Effects of Drugs
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study of NT 201 in Adults With Moderate to Severe Platysma Prominence in Europe (PLATINUM EU) NT 201, NT 201 Placebo - Neuromuscular Agents, Peripheral Nervous System Agents | Phase 3 | Active not recruiting | Merz Aesthetics GmbH | 300 | 2025-10-01 | 2026-11-06 |
| The Study of Efficacy and Safety of Dimephosphon® in Acute Ischemic Stroke Dimephosphon®, Placebo - Stroke, Acute Stroke | Phase 3 | Recruiting | Tatchempharmpreparaty, JSC | 184 | 2025-09-06 | 2025-09-11 |
| A Study of NT 201 in Adults With Moderate to Severe Platysma Prominence in the United States NT 201, NT 201 Placebo - Neuromuscular Agents, Peripheral Nervous System Agents | Phase 3 | Active not recruiting | Merz North America, Inc. | 300 | 2025-08-27 | 2026-09-10 |
| A Study of Abemaciclib (LY2835219) With Abiraterone in Men With Prostate Cancer That Has Spread to Other Parts of the Body and is Expected to Respond to Hormonal Treatment (Metastatic Hormone-Sensitive Prostate Cancer) Abemaciclib, Abiraterone, Prednisone or Prednisolone - Prostatic Neoplasms, Neoplasm Metastasis | Phase 3 | Active not recruiting | Eli Lilly and Company | 925 | 2022-04-14 | 2026-07-01 |
| Immunomodulatory Effect of Dexmedetomidine as an Adjuvant Drug in Laparoscopic Cholecystectomies Dexmedetomidine Hydrochloride - Physiological Effects of Drugs | Phase 3 | Unknown | Universidade Federal do Rio de Janeiro | 52 | 2022-04-01 | 2022-08-05 |
Cerebrovascular Disorders (1) · Ischemic Stroke (1) · Neoplasm Metastasis (1) · Prostatic Neoplasms (1) · Stroke (1) · Urogenital Neoplasms (1)
Brain Diseases (1) · Cardiovascular Diseases (1) · Central Nervous System Diseases (1) · Female Urogenital Diseases (1) · Female Urogenital Diseases and Pregnancy Complications (1) · Genital Diseases (1) · Genital Diseases, Male (1) · Genital Neoplasms, Male (1) · Male Urogenital Diseases (1) · Neoplasms (1) · Neoplasms by Site (1) · Neoplastic Processes (1) · Nervous System Diseases (1) · Pathologic Processes (1) · Pathological Conditions, Signs and Symptoms (1)
incobotulinumtoxinA (2) · Dexmedetomidine (1) · Prednisolone (1) · Prednisone (1) · abemaciclib (1) · abiraterone (1) · dimephosphon (1)
Eli Lilly and Company (1) · Merz Aesthetics GmbH (1) · Merz North America, Inc. (1) · Tatchempharmpreparaty, JSC (1) · Universidade Federal do Rio de Janeiro (1)
Brazil (2) · France (2) · Germany (2) · Poland (2) · Spain (2) · United States (2) · Argentina (1) · Australia (1) · Belgium (1) · Canada (1) · China (1) · Czechia (1) · Greece (1) · Hungary (1) · Israel (1)